Search Bar & Filters
Found 2 Actively Recruiting clinical trials
Actively Recruiting
Researchers are conducting a prospective, randomized, controlled trial to compare pain levels experienced by patients after intravitreal injections when using two different anesthetics Iheezo Chloroprocaine HCl ophthalmic gel 3% and subconjunctival Lidocaine 2%. The study aims to determine if Iheezo is not inferior to Lidocaine in reducing pain up to 24 hours post-injection. The trial is sponsored by Retina Research Institute, LLC and involves about 80 participants. Participants will be randomly assigned to receive either Iheezo, a topical anesthetic gel, or subconjunctival Lidocaine, an injection anesthetic, before their intravitreal injection procedure. Both treatments are approved for pre-procedure anesthesia. The study uses a parallel design with double masking to assess and compare the pain scores associated with each anesthetic over the 24-hour period following the injection. During the study, participants will undergo intravitreal injections with one of the study anesthetics, and their pain levels will be measured up to 24 hours afterward. The primary outcome is pain scores assessed at 4 hours post-injection. Participants will be monitored throughout the study period to collect these pain assessments. The total duration of participation spans from screening through the completion of the post-injection evaluation.
Actively Recruiting
Researchers are studying Medicare beneficiaries with Lumbar Spinal Stenosis LSS and Neurogenic Claudication NC to compare outcomes after two different procedures MILD Percutaneous Image-Guided Lumbar Decompression and Interspinous Process Decompression IPD. This observational study tracks patients treated since January 1, 2017, evaluating the rates of surgical and minimally invasive interventions as well as any harms related to these procedures over 24 months. The study uses Medicare claims data and does not require prior patient consent or IRB oversight. The study includes two groups of patients those who received the MILD procedure, involving partial decompression under image guidance by removing tissue and bone at the affected spinal level, and those who underwent IPD, a device-based decompression technique. Both groups are observed through Medicare data for two years after their initial procedure to assess the need for further surgeries or interventions and to monitor for any complications. Participants are followed for 24 months after their index procedure using Medicare claims data. Researchers monitor the rates of harms associated with the initial treatment and the frequency of additional surgical or minimally invasive interventions. Since this is an observational study, data collection relies on existing Medicare records without direct patient involvement, and the study will continue enrolling patients until the sponsor stops it.